Variability of X chromosome inactivation: Effect on levels of TIMP1 RNA and role of DNA methylation

Human Genetics

Volumn 110, Issue 3, 2002, Pages 271-278

  Anderson, Catherine L ^b   Brown, Carolyn J ^a,b  

^a University of British Columbia ^*  (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; PROTEIN; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AGE; ALLELE; ARTICLE; CELL AGGREGATION; CELL LINE; CHROMOSOME INACTIVATION; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE PREDISPOSITION; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYBRID CELL; LYMPHOBLAST; MALE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; RIBONUCLEASE PROTECTION ASSAY; RODENT; SEX DIFFERENCE; SOMATIC CELL; X CHROMOSOME; X CHROMOSOME LINKAGE;

AGING; ALLELES; ANIMALS; CELL LINE; DNA METHYLATION; DOSAGE COMPENSATION, GENETIC; FEMALE; GENE EXPRESSION; HUMANS; HYBRID CELLS; MALE; PROMOTER REGIONS (GENETICS); RNA; SEX CHARACTERISTICS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; X CHROMOSOME;

RODENTIA;

EID: 0036524026     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-002-0676-8     Document Type: Article

References (40)

1. Anderson CL, Brown CJ (1999) Polymorphic X-chromosome inactivation of the human TIMP1 gene. Am J Hum Genet 65:699-708
2. Arthur MJ, Iredale JP, Mann DA (1999) Tissue inhibitors of metalloproteinases: Role in liver fibrosis and alcoholic liver disease. Alcohol Clin Exp Res 23:940-943
3. Avner P, Heard E (2001) X-chromosome inactivation: Counting, choice and initiation. Nat Rev Genet 2:59-67
4. Brown CJ, Carrel L, Willard HF (1997) Expression of genes from the human active and inactive X chromosomes. Am J Hum Genet 60:1333-1343
5. Carrel L, Willard HF (1999) Heterogeneous gene expression from the inactive X chromosome: An X-linked gene that escapes X inactivation in some human cell lines but is inactivated in others. Proc Natl Acad Sci USA 96:7364-7369
6. Carrel L, Hunt PA, Willard HF (1996) Tissue and lineage-specific variation in inactive X chromosome expression of the murine Smcx gene. Hum Mol Genet 5:1361-1366
7. Carrel L, Cottle AA, Goglin KC, Willard HF (1999) A first-generation X-inactivation profile of the human X chromosome. Proc Natl Acad Sci USA 96:14440-14444
8. Chen C, Yang MC, Yang TP (2001) Evidence that silencing of the HPRT promoter by DNA methylation is mediated by critical CpG sites. J Biol Chem 276:320-328
9. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
10. Clark IM, Rowan AD, Edwards DR, Bech-Hansen T, Mann DA, Bahr MJ, Cawston TE (1997) Transcriptional activity ofthe human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem J 324:611-617
11. Dean G, Young DA, Edwards DR, Clark IM (2000) The human tissue inhibitor of metalloproteinases (TIMP)-1 gene contains repressive elements within the promoter and intron 1. J Biol Chem 275:32664-32671
12. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM (1993) Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions. Pharmacol Ther 59:329-341
13. Disteche CM (1995) Escape from X inactivation in human and mouse. Trends Genet 11:17-22
14. Disteche CM (1999) Escapees on the X chromosome. Proc Natl Acad Sci USA 96:14180-14182
15. Doyle GA, Saarialho-Kere UK, Parks WC (1997) Distinct mechanisms regulate TIMP-1 expression at different stages of phorbol ester-mediated differentiation of U937 cells. Biochemistry 36:2492-2500
16. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP (1997) Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 74:111-122
17. Goodfellow P, Pym B, Mohandas T, Shapiro LJ (1984) The cell surface antigen locus, MIC2X, escapes X-inactivation. Am J Hum Genet 36:777-782
18. Goodfellow PJ, Mondello C, Darling SM, Pym B, Little P, Goodfellow PN (1988) Absence of methylation of a CpG-rich region at the 5′ end of the MIC2 gene on the active X, the inactive X, and the Y chromosome. Proc Natl Acad Sci USA 85:5605-5609
19. Goodfellow PN, Camerino G (2001) DAX-1, an "antitestis" gene. Exs 91:57-69
20. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M (1998) In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 102:2002-2010
21. Hansen RS, Stoger R, Wijmenga C, Stanek AM, Canfield TK, Luo P, Matarazzo MR, D'Esposito M, Feil R, Gimelli G, Weemaes CM, Laird CD, Gartler SM (2000) Escape from gene silencing in ICF syndrome: Evidence for advanced replication time as a major determinant. Hum Mol Genet 9:2575-2587
22. Itoh Y, Nagase H (1995) Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem 270:16518-16521
23. Jeppesen P, Turner BM (1993) The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression. Cell 74:281-289
24. Jones PL, Wolffe AP (1999) Relationships between chromatin organization and DNA methylation in determining gene expression. Semin Cancer Biol 9:339-347
25. Lee MA, Palace J, Stabler G, Ford J, Gearing A, Miller K (1999) Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain 122:91-197
26. Lukashev ME, Werb Z (1998) ECM signalling: Orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8:437-441
27. Lyon MF (1961) Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 190:372-373
28. Migeon BR (1972) Stability of X chromosomal inactivation in human somatic cells. Nature 239:87-89
29. Migeon BR, Shapiro LJ, Norum RA, Mohandas T, Axelman J, Dabora RL (1982) Differential expression of steroid sulphatase locus on active and inactive human X chromosome. Nature 299:838-840
30. Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491-21494
31. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58:5321-5325
32. Schempp W, Meer B (1983) Cytologic evidence for three human X-chromosomal segments escaping inactivation. Hum Genet 63:171-174
33. Sistermans EA, De Coo RF, De Wijs IJ, Van Oost BA (1998) Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease. Neurology 50:1749-1754
34. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98:137-146
35. Sykes AP, Bhogal R, Brampton C, Chander C, Whelan C, Parsons ME, Bird J (1999) The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease. Aliment Pharmacol Ther 13:1535-1542
36. Tsuchiya KD, Willard HF (2000) Chromosomal domains and escape from X inactivation: Comparative X inactivation analysis in mouse and human. Mamm Genome 11:849-854
37. Vignola AM, Kips J, Bousquet J (2000) Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 105:1041-1053
38. Yen PH, Patel P, Chinault AC, Mohandas T, Shapiro LJ (1984) Differential methylation of hypoxanthine phosphoribosyltransferase genes on active and inactive human X chromosomes. Proc Natl Acad Sci USA 81:1759-1763
39. Yip D, Ahmad A, Karapetis CS, Hawkins CA, Harper PG (1999) Matrix metalloproteinase inhibitors: Applications in oncology. Invest New Drugs 17:387-399
40. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455-461